Contact us
Mobile menu not yet fully implemented
Access to risk finance aims to overcome deficits in the availability of debt and equity finance for R&D and innovation-driven companies and projects at all stages of development by supporting the development of Union-level venture capital.
info@ncpflanders.be
+32 2 550 15 65
The concrete goal of access to risk finance under Horizon 2020 is to support and facilitate access to sources of debt and equity financing by innovative companies of all sizes and also by research centers and universities etc.
This support is given through financial intermediaries.
Infosheets contain edited content on aspects related to this programme. They are reviewed at least yearly.
Related links are easy pointers towards external information. We curate the list, but are not liable for the destinations.
Documents contain additional information related to this programme, and are similar to related links.
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
